NovaBay Pharmaceuticals, Inc. (NBY) owns Avenova, which is EPA listed as an effective disinfectant for monkeypox. On 5/20/2022 Ascendiant Capital Markets brokerage set a price target of $4.00 for NovaBay Pharmaceuticals, Inc. (NBY). The stock is now only 0.20usd. Before the pandemic news, on their last earnings, they mentioned that Avenova Spray unit sales...
If trends continues they'll be some good thick candles to scalp off their wic. Gotta keep an eye on this one :)
Please note: just sharing my view. its not a recommendation for buying or selling.
AMEX:NBY Trading in a channel, sitting on bottom, looking for a bounce off bottom channel this week towards midline. tight stop loss of $0.85 and looking at a profit to risk ratio of about 10:1. Get it. Go long
$NBY i'll be looking tomorrow for a gap up and then a pop into the $4.50 half dollar resistance that I will short. Keep your stops tight if the lower high doesn't hold and keeps breaking up because it can run to $5